X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Details:
The collaboration aims to focus on the research and development of ANEW’s patented Klotho gene therapy in enhancing longevity and reducing age-related diseases.
Lead Product(s): Klotho Gene Therapy
Therapeutic Area: Cardiology/Vascular Diseases Product Name: Undisclosed
Highest Development Status: IND EnablingProduct Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Japan’s Okinawa Research Center
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Partnership June 27, 2024
Details:
ANEW intends to use the proceeds from the transaction to progress its lead gene therapy programs including, Alpha Klotho-based gene therapy being developed for the treatment of amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD).
Lead Product(s): Alpha Klotho-based Gene Therapy
Therapeutic Area: Neurology Product Name: Undisclosed
Highest Development Status: N/AProduct Type: Cell and Gene therapy
Partner/Sponsor/Collaborator: Redwoods Acquisition Corp.
Deal Size: Undisclosed Upfront Cash: Undisclosed
Deal Type: Merger May 30, 2023
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] 
Market Place
